Promore – Reports and prospectus

Interim Reports (Promore) November 21, 2017 Delårsrapport januari – september 2017	Report (pdf)
Interim Reports (Promore) November 21, 2017 Interim report January – September 2017	Report (pdf)
Interim Reports (Promore) August 30, 2017 Delårsrapport januari – juni 2017	Report (pdf)
Interim Reports (Promore) August 30, 2017 Interim report January – June 2017	Report (pdf)
Prospectus (Promore) June 7, 2017 Listing on Nasdaq First North	Prospekt (pdf)
Interim Reports (Promore) May 19, 2017 Delårsrapport januari – mars 2017	Report (pdf)
Interim Reports (Promore) May 19, 2017 Interim report January – March 2017	Report (pdf)
Annual Reports (Promore) May 17, 2017 Årsredovisning Juli 2015 – December 2016	Report (pdf)
Annual Reports (Promore) May 17, 2017 Annual Report July 2015 – December 2016	Report (pdf)
Annual Reports (Promore) April 25, 2017 Pergamum AB – Årsredovisning Juli 2015 – December 2016	Report (pdf)
Annual Reports (Promore) April 25, 2017 Pergamum AB – Annual Report July 2015 – December 2016	Report (pdf)

MESSAGE FROM THE CEO

Read what our CEO has to say about our business.

Read the CEO message

BUSINESS MODEL

The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.

Learn more about the business model

VISION

To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.

MISSION

To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.